Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma

Cancer
Tawee Tanvetyanon, Abdul M Choudhury

Abstract

Anemia is a well-recognized complication of concurrent chemoradiation therapy for head and neck carcinoma. It impairs quality of life and many studies also have reported an association between anemia and increased tumor recurrence and decreased long-term survival. In the current study, the authors attempted to identify the severity, risk factors, and physician practices in the management of anemia. Medical records of those patients receiving concurrent chemoradiation for head and neck carcinoma between 1999-2003 were reviewed. The average weekly nadir hemoglobin level (AWNH) was defined as the mean value of the lowest hemoglobin concentration in each week. Independent predictors for an AWNH < 11 g/dL were identified using multivariable logistic regression analyses. Seventy-two patients were included in the current study, 66.7% of whom had unresectable disease. The overall median survival was 402 days. At baseline, 76.4% (95% confidence interval [95% CI], 66.3-86.4%) of patients already had a hemoglobin level < 13.5 g/dL. The hemoglobin level dropped 2.5 +/- 1.9 g/dL during concurrent chemoradiation, resulting in 95.8% of patients having a hemoglobin level < 13.5 g/dL at the end of the observation period. Blood was transfused to...Continue Reading

References

May 1, 1989·International Journal of Radiation Oncology, Biology, Physics·E P DunphyM A Bagshaw
Mar 1, 1988·Biochemical Pharmacology·G MilanoM Schneider
Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D A FeinL R Coia
Oct 23, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P StadlerM Molls
Jun 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J LittlewoodUNKNOWN Epoetin Alfa Study Group
Sep 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Douglas RizzoUNKNOWN American Society of Clinical Oncology. American Society of Hematology
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J AdelsteinArlene A Forastiere
Jun 17, 2003·Carcinogenesis·Yoshiko YasudaHiroshi Utsumi
Aug 7, 2003·The Lancet Oncology·Brian Leyland-Jones, UNKNOWN BEST Investigators and Study Group
Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Athanassios ArgirisArlene A Forastiere
Jan 16, 2004·Critical Care Medicine·Lawrence T Goodnough
Feb 6, 2004·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Monika JandaRichard Poetter

❮ Previous
Next ❯

Citations

Jul 17, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lorenzo GianniAlberto Ravaioli
Jun 15, 2015·World Journal of Surgical Oncology·Chun-Ming HuangChih-Jen Huang
Apr 29, 2021·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·Görkem EskiizmirYasemin Başpınar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
D PapamichaelSIOG
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Paolo PedrazzoliSalvatore Siena
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
I MaestuA Albert
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
S RicciP F Conte
© 2021 Meta ULC. All rights reserved